Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
First-line pembrolizumab in cisplatin-ineligible patients... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
0
Authors
Arjun Balar
•
Stephen Keefe
14 more
•
Joaquim Bellmunt
Published
September 26, 2017
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Cancer Oncology
Internal Medicine
Surgery
Medicine
Cancer Oncology
Internal Medicine
Surgery
Response Evaluation Criteria In Solid Tumors
Show all topics
DOI
10.1016/s1470-2045(17)30616-2
